Results 131 to 140 of about 9,266 (196)

Semaphorin 3A and 3F Promote Lumen Expansion in TIE2-Mutated Venous Malformation. [PDF]

Arterioscler Thromb Vasc Biol
Schrenk S, Sherpa C, Bischoff LJ, Cai Y, Boscolo E.   +4 more
europepmc   +1 more source

Extract of Scutellaria baicalensis induces semaphorin 3A production in human epidermal keratinocytes. [PDF]

PLoS One, 2021
Yoshioka Y, Kamata Y, Tominaga M, Umehara Y, Yoshida I, Matsuoka N, Takamori K.   +6 more
europepmc   +1 more source

Plasma Semaphorin 3A as a Potential Biomarker for Cognitive Impairment in Cerebral Small Vessel Disease. [PDF]

Int J Gen Med
Ma H, Li H, Fu X, Li X, Wei C, Ma A.
europepmc   +1 more source

Semaphorin 3A mitigates lipopolysaccharide-induced chondrocyte inflammation, apoptosis and extracellular matrix degradation by binding to Neuropilin-1. [PDF]

Bioengineered, 2021
Zhang H, Lu Y, Wu B, Xia F.
europepmc   +1 more source

Semaphorin 3A and its role in osteoprotection

BoneKEy Reports, 2012
openaire   +3 more sources

Silicified collagen scaffold induces semaphorin 3A secretion by sensory nerves to improve in-situ bone regeneration. [PDF]

Bioact Mater, 2022
Ma YX, Jiao K, Wan QQ, Li J, Liu MY, Zhang ZB, Qin W, Wang KY, Wang YZ, Tay FR, Niu LN.   +10 more
europepmc   +1 more source

Inhibition of Semaphorin 3A in Hippocampus Alleviates Postpartum Depression-Like Behaviors in Mice. [PDF]

Mol Neurobiol
Chen Q, Xu F, Wu H, Xie L, Li H, Jiao C, Zhang H, Chen X.   +7 more
europepmc   +1 more source

Expression of Semaphorin 3A in Malignant and Normal Bladder Tissue: Immunohistochemistry Staining and Morphometric Evaluation. [PDF]

Biology (Basel), 2021
Bejar I, Rubinstein J, Bejar J, Sabo E, Sheffer H, Bahouth Z, Halachmi S, Vadasz Z.   +7 more
europepmc   +1 more source

Lentiviral Mediated Expression of Soluble Neuropilin 1 Inhibits Semaphorin 3A-mediated Collapse Activity in Vitro. [PDF]

Basic Clin Neurosci, 2021
Nedaei K, Hesaraki M, Mazloomzadeh S, Totonchi M, Biglari AR.   +4 more
europepmc   +1 more source

Plain language summary of publication of new targets in diabetic retinopathy including a protein called semaphorin 3A: addressing limitations of current treatments. [PDF]

Ther Adv Ophthalmol
Sivaprasad S, Barker R, Zippel N.
europepmc   +1 more source